CME Group Inc [CME] stock prices are up 1.14% to $277.74 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CME shares have gain 0.46% over the last week, with a monthly amount glided 0.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on July 24, 2025, when UBS downgraded its rating to a Neutral but kept the price target unchanged to $305 for it. Previously, Morgan Stanley upgraded its rating to Overweight on April 08, 2025, and kept the price target unchanged to $301. On March 10, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $287 on the stock. Citigroup downgraded its rating to a Neutral and decreased its price target to $250 on January 06, 2025. Redburn Atlantic downgraded its rating to a Neutral but $244 remained the price target by the analyst firm on October 08, 2024. RBC Capital Mkts started tracking with a Sector Perform rating for this stock on September 27, 2024, and assigned it a price target of $235. In a note dated September 26, 2024, TD Cowen initiated an Hold rating and provided a target price of $221 on this stock.
The stock price of CME Group Inc [CME] has been fluctuating between $188.56 and $290.79 over the past year. Currently, Wall Street analysts expect the stock to reach $292.5 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $277.74 at the most recent close of the market. An investor can expect a potential return of 5.31% based on the average CME price forecast.
Analyzing the CME fundamentals
The CME Group Inc [NASDAQ:CME] reported sales of 6.44B for trailing twelve months, representing a surge of 10.41%. Gross Profit Margin for this corporation currently stands at 0.87% with Operating Profit Margin at 0.65%, Pretax Profit Margin comes in at 0.75%, and Net Profit Margin reading is 0.58%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.14 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 274.77 points at the first support level, and at 271.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 279.50, and for the 2nd resistance point, it is at 281.27.
Ratios To Look Out For
It’s worth pointing out that CME Group Inc [NASDAQ:CME]’s Current Ratio is 1.02. As well, the Quick Ratio is 1.02, while the Cash Ratio is 0.01. Considering the valuation of this stock, the price to sales ratio is 15.53, the price to book ratio is 3.60 and price to earnings (TTM) ratio is 26.88.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Jun 25 ’25 when 256.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Jun 25 ’25 to buy 11.0 shares. Meanwhile, Director Carey Charles P sold 500.0 shares on Jun 10 ’25.
